{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:14:52Z","timestamp":1780362892858,"version":"3.54.1"},"reference-count":33,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: This study evaluates the diagnostic accuracy of [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET) using bone marrow biopsy (BMB) and clinical follow-up as reference standards. It further identifies predictive factors for bone marrow involvement (BMI) in non-Hodgkin lymphoma (NHL) patients. Methods: NHL patients who underwent [18F]FDG PET and BMB at diagnosis in a tertiary cancer center were included in this study. Diagnostic accuracy was analyzed, and logistic regression was performed to identify BMI predictors using Stata software version 17. A retrospective analysis of 262 NHL patients was conducted. Results: Concordance rates between [18F]FDG PET and BMB and between [18F]FDG PET and clinical follow-up were 75.6% and 88.1%, respectively. The primary cause of discordance between [18F]FDG PET and BMB was the detection of extra-iliac focal hypermetabolic bone marrow lesions by [18F]FDG PET, which were negative on BMB. The sensitivity, specificity, and accuracy of [18F]FDG PET were 62.9%, 80%, and 75.6%, respectively, with BMB as a reference, and 74.1%, 97.5%, and 88.2%, respectively, with clinical follow-up as a reference. The focal bone marrow [18F]FDG pattern was the most reliable indicator of BMI. Univariate logistic regression showed that advanced NHL stage, elevated alkaline phosphatase, thrombocytopenia, leukopenia, and elevated lactate dehydrogenase were significant predictors of BMI. Multivariate analysis revealed advanced NHL stage and thrombocytopenia as clinical predictors. Conclusions: [18F]FDG PET is a reliable tool for assessing BMI, providing comprehensive total-body evaluation and identifying extra-iliac involvement beyond the scope of BMB. The collective interpretation of molecular imaging, clinical, and biochemical factors is crucial for predicting BMI.<\/jats:p>","DOI":"10.3390\/cancers17020231","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T05:40:40Z","timestamp":1736746840000},"page":"231","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-4716","authenticated-orcid":false,"given":"Akram","family":"Al-Ibraheem","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"},{"name":"School of Medicine, University of Jordan, Al-Jubeiha, Amman 11942, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-5110","authenticated-orcid":false,"given":"Ahmad Saad","family":"Abdlkadir","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Hasasna","sequence":"additional","affiliation":[{"name":"Department of Cell Therapy & Applied Genomics, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Alalawi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mohamedkhair","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4227-8658","authenticated-orcid":false,"given":"Salem","family":"Al-Yazjeen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahed","family":"Obeidat","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obayda","family":"Rabei","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4173-0996","authenticated-orcid":false,"given":"Dua\u2019a","family":"Al-Jarrah","sequence":"additional","affiliation":[{"name":"Department of Pathology, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Shahin","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7492-6374","authenticated-orcid":false,"given":"Kamal","family":"Al-Rabi","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5103-0694","authenticated-orcid":false,"given":"Mohammad","family":"Makoseh","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6009-7906","authenticated-orcid":false,"given":"Nidal","family":"Almasri","sequence":"additional","affiliation":[{"name":"Department of Pathology, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"ref_1","first-page":"34","article-title":"Lymphoma: Diagnosis and treatment","volume":"101","author":"Lewis","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jclinpath-2013-201520","article-title":"Bone marrow trephine biopsy involvement by lymphoma: Review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings","volume":"67","author":"Sovani","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1990.8.7.1163","article-title":"Bone marrow involvement by non-Hodgkin\u2019s lymphoma: The clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group","volume":"8","author":"Conlan","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/1097-0142(197602)37:2<629::AID-CNCR2820370204>3.0.CO;2-K","article-title":"Bone marrow involvement in non-Hodgkin\u2019s lymphoma. Implications for staging and therapy","volume":"37","author":"Stein","year":"1976","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3816\/CLM.2004.n.010","article-title":"A large-scale study of bone marrow involvement in patients with Hodgkin\u2019s lymphoma","volume":"5","author":"Levis","year":"2004","journal-title":"Clin. Lymphoma"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/jcp.2004.022178","article-title":"Bone marrow biopsy morbidity: Review of 2003","volume":"58","author":"Bain","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00256-021-03882-w","article-title":"Bone marrow aspiration and biopsy: Techniques and practice implications","volume":"51","author":"Tomasian","year":"2022","journal-title":"Skeletal Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcla.20008","article-title":"A pathologist\u2019s perspective on bone marrow aspiration and biopsy: I. Performing a bone marrow examination","volume":"18","author":"Riley","year":"2004","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.semnuclmed.2022.11.001","article-title":"PET\/CT in non-Hodgkin lymphoma: An update","volume":"53","author":"Zanoni","year":"2023","journal-title":"Semin. Nucl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Almaimani, J., Tsoumpas, C., Feltbower, R., and Polycarpou, I. (2022). FDG PET\/CT versus Bone Marrow Biopsy for Diagnosis of Bone Marrow Involvement in Non-Hodgkin Lymphoma: A Systematic Review. Appl. Sci., 12.","DOI":"10.3390\/app12020540"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.semnuclmed.2022.10.006","article-title":"PET\/CT in Hodgkin lymphoma: An update","volume":"53","author":"Mottaghy","year":"2023","journal-title":"Semin. Nucl. Med."},{"key":"ref_12","first-page":"1860","article-title":"Report of the committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1016\/j.crad.2021.02.023","article-title":"Prognostic significance of bone marrow 2-[18F]-fluoro-2-deoxy-d-glucose uptake in diffuse large B-cell lymphoma: Relation to iliac crest biopsy results","volume":"76","author":"Lim","year":"2021","journal-title":"Clin. Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1007\/s00259-021-05348-6","article-title":"FDG PET\/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: Results from the prospective, multicenter PETAL and OPTIMAL>60 trials","volume":"48","author":"Altmann","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1097\/RLU.0000000000002516","article-title":"Diagnostic and Prognostic Value of Using 18F-FDG PET\/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma","volume":"44","author":"Abe","year":"2019","journal-title":"Clin. Nucl. Med."},{"key":"ref_16","first-page":"203","article-title":"Measures of Diagnostic Accuracy: Basic Definitions","volume":"19","year":"2009","journal-title":"EJIFCC"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/sim.1768","article-title":"Sample size and power for McNemar\u2019s test with clustered data","volume":"23","year":"2004","journal-title":"Stat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1182\/bloodadvances.2020001579","article-title":"Baseline FDG-PET\/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information","volume":"4","author":"Nakajima","year":"2020","journal-title":"Blood Adv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00259-006-0238-8","article-title":"Bone involvement in patients with lymphoma: The role of FDG-PET\/CT","volume":"34","author":"Schaefer","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ajh.24044","article-title":"The role of bone marrow biopsy and FDG-PET\/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. accuracy in a multicenter series of 372 patients","volume":"90","author":"Jerez","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_21","first-page":"e34901","article-title":"The Diagnostic Accuracy of Bone Marrow Biopsy Versus PET\/CT Scan in Identifying Bone Marrow Involvement in Diffuse Large B Cell Lymphoma Patients at a Cancer Hospital","volume":"15","author":"Asif","year":"2023","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Han, E.J., O, J.H., Yoon, H., Ha, S., Yoo, I.R., Min, J.W., Choi, J.I., Choi, B.O., Park, G., and Lee, H.H. (2022). Comparison of FDG PET\/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics. Diagnostics, 12.","DOI":"10.3390\/diagnostics12010222"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1634\/theoncologist.2015-0036","article-title":"Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography","volume":"20","author":"Meignan","year":"2015","journal-title":"Oncologist"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s13139-012-0153-9","article-title":"Usefulness of 18 F-FDG PET\/CT for the evaluation of bone marrow involvement in patients with high-Grade Non-hodgkin\u2019s lymphoma","volume":"46","author":"Lee","year":"2012","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/COC.0b013e318168d90b","article-title":"The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma","volume":"31","author":"Muslimani","year":"2008","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MNM.0000000000001139","article-title":"Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET\/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma","volume":"41","author":"Kandeel","year":"2020","journal-title":"Nucl. Med. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2910","DOI":"10.1097\/MD.0000000000002910","article-title":"The Value of PET\/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma","volume":"95","author":"Perry","year":"2016","journal-title":"Medicine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.semnuclmed.2021.06.014","article-title":"FDG-PET\/CT variants and pitfalls in haematological malignancies","volume":"51","author":"Pilkington","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2967\/jnumed.112.114710","article-title":"In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET\/CT provides better diagnostic performance and prognostic stratification than does biopsy","volume":"54","author":"Berthet","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clml.2011.09.215","article-title":"Prognostic value of platelet count in diffuse large B-cell lymphoma","volume":"12","author":"Chen","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-016-2819-3","article-title":"Utility of a simple prognostic stratification based on platelet counts and serum albumin levels in elderly patients with diffuse large B cell lymphoma","volume":"96","author":"Ochi","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_33","first-page":"79","article-title":"18f-fluorodeoxyglucose positron emission tomography versus bone marrow biopsy for the evaluation of bone marrow infiltration in newly diagnosed lymphoma patients","volume":"73","year":"2021","journal-title":"Rev. Investig. Clin."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/2\/231\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:27:35Z","timestamp":1759919255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/2\/231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["cancers17020231"],"URL":"https:\/\/doi.org\/10.3390\/cancers17020231","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}